Stem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.

The Russian Journal of Developmental Biology, published by PLEIADES PUBLISHING INC, serves as a significant platform for researchers and professionals engaged in the field of developmental biology. With the ISSN 1062-3604 and E-ISSN 1608-3326, this journal focused on intricate biological processes and dynamic developmental mechanisms from 2005 until 2017. Although its coverage is currently discontinued in Scopus, it remains notable for its contribution to understanding the pivotal roles of biochemistry and molecular genetics within the context of development. As a publication situated in the competitive quartiles of the field and boasting an influential Scopus rank of #77 out of #78, it has made a unique mark in developmental studies. Researchers and academics seeking to enhance their knowledge of historical advancements in the discipline will find the journal a valuable resource, even as it navigates the transition away from active publication.

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

Stem Cells and Cloning-Advances and Applications is a leading peer-reviewed journal dedicated to the dynamic fields of stem cell research and cloning technologies. Published by DOVE MEDICAL PRESS LTD in New Zealand since 2008, this Open Access journal ensures that groundbreaking findings are accessible to a global audience. With a focus on innovative applications and advancements in cellular biology, the journal plays a pivotal role in disseminating knowledge within the scientific community. The journal currently holds an impact factor that reflects its influence, with notable rankings in both Cell Biology and Medicine (Miscellaneous), showcasing its interdisciplinary relevance. Researchers, professionals, and students alike benefit from the journal’s wide-ranging contributions, covering critical topics from regenerative medicine to genetic research. With a commitment to fostering collaboration and encouraging discussion in these cutting-edge domains, Stem Cells and Cloning-Advances and Applications continues to be a vital resource for advancing scientific inquiry and application.

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

CYTOTHERAPY is a distinguished journal published by Elsevier Science Ltd, focusing on the critical fields of cell therapy, transplantation, and regenerative medicine. Since its inception in 1999, the journal has established itself as a vital resource for researchers and practitioners, contributing significantly to advancements in Cancer Research, Cell Biology, Genetics, Immunology, and Oncology. With an impressive range of Q2 rankings across multiple categories and a remarkable Q1 standing in Transplantation for 2023, CYTOTHERAPY delivers high-impact research that addresses the evolving challenges in these fields. While the journal does not offer open access, it remains a reputable avenue for disseminating pivotal studies and reviews that push the boundaries of cell-based therapies. Researchers, clinicians, and students alike will find CYTOTHERAPY an indispensable platform to stay abreast of the latest discoveries and innovations that are shaping the future of medical science.